Herpesvirus 6 Antibody (IgM)
Use
This serologic test for HHV‑6 IgM antibodies is intended to identify recent primary infection, reactivation, or reinfection of human herpesvirus‑6 (HHV‑6), particularly useful in immunocompromised individuals or infants presenting with clinical features consistent with roseola or neurological involvement.
Special Instructions
Not provided.
Limitations
IgM serology may not differentiate between HHV‑6 subtypes and can yield false positive or cross‑reactive results. Serology may not reflect active infection—PCR testing may be preferred in suspected active disease. IgM may disappear early or reappear during reactivation; interpret in clinical context.
Methodology
Immunoassay (IFA)
Biomarkers
HHV‑6 IgM Antibody
Protein
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1‑1.5 mL whole blood drawn; yields approx 0.5 mL serum
Minimum Volume
0.1 mL serum
Container
Red top (no additive) tube
Collection Instructions
Collect whole blood, separate serum.
Other tests from different labs that may be relevant